# LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
> **NDA203076** · New Drug Application · Sponsor: CIPLA LTD · Approved 2012-10-16
## Drug
- **FDA Application Number:** NDA203076
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL SUSPENSION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LTD
- **First approval:** 2012-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203076)
---
*MORVS · CC0 1.0*